Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT06532253

Long-term Safety Trial with NVDX3 (X3LTFU)

Long-term Safety Bucket Trial with NVDX3, an Osteogenic Implant of Human Allogenic Origin.

Sponsor: Data Investigation Company Europe (DICE)

Conditions Degenerative Lumbar Spondylolisthesis Distal Radius Fractures

Interventions NVDX3

Updated 3 times since 2024 Last updated: Sep 1, 2024 Started: Aug 22, 2024 Primary completion: Mar 31, 2036 Completion: Mar 31, 2036

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06532253, this PHASE1/PHASE2 trial focuses on Degenerative Lumbar Spondylolisthesis and Distal Radius Fractures and remains actively recruiting participants. Sponsored by Data Investigation Company Europe (DICE), it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Oct 2024 — Present [monthly]

Recruiting PHASE1/PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting PHASE1/PHASE2
Aug 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE1/PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Data Investigation Company Europe (DICE)
Novadip Biosciences
PrimeVigilance

Data source: Novadip Biosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Luxembourg, Luxembourg